Search Results (570)

Radiotherapy is one of the conventional methods for the treatment of cancers. Boron neutron capture therapy (BNCT) has emerged as a promising and well-recognized modality for treating certain types of cancers. BNCT is a binary radiotherapy that largely depends on neutron beams and ¹⁰B carriers. Although an “ideal” boron carrier should fulfill multiple criteria, high tumor/normal tissue ratio (T/N > 5) and high tumor uptake of boron (>20 μg/g) are critically important. First-generation (boric acid and derivatives) and second-generation (BPA and BSH) boron carriers suffer from poor T/N and extremely high dose in clinical use (500 mg/kg and usually >30 g for each patient). Glucose transporter 1 (GLUT1) is overexpressed on the membrane surface of multiple tumors and is a potential target for third-generation boron carrier to achieve high T/N and high tumor uptake of boron. However, the boron-bearing sugar derivatives designed in the last few decades have suffered from suboptimal T/N values and significant cytotoxicity. In the present study, a total of two categories comprising 6 series (28 in total) of boron-bearing sugar derivatives were designed and synthesized and their cellular boron uptake, T/N, and cytotoxicity were evaluated. The structure–activity relationship (SAR) of these target compounds was analyzed, and one of the target compounds, B3, a phenyl C-mannoside with an o-carborane moiety, exhibited the best boron-carrying profile, which featured 10.6-fold higher boron uptake by the SCC-9 cell line and a largely improved T/N (3.3 for B3 vs. 1.4 for BPA) compared with the current clinical gold standard BPA. Therefore, the chemical structure of B3 represents a privileged candidate structure for the future design of “ideal” boron carriers for BNCT. Full article

Photochromic diarylethene molecules are promising candidates for applications in optical data storage devices. However, many reported diarylethene compounds suffer from inefficiencies due to low photocyclization quantum yields or poor fatigue resistance. To address this issue, we have developed a highly efficient boron–nitrogen heterocycle-bridged diarylethene. The bulky boron–nitrogen heterocyclic ethene bridge blocks interconversion between parallel and anti-parallel conformations, yielding two separated rotamers. Evaluation of their photochromic properties demonstrated that the anti-parallel conformer exhibits a high photocyclization quantum yield (Φ_o-c, 89.2%), excellent thermodynamic stability at 298 K and moderate fatigue resistance in hexane. Furthermore, direct comparison with its isosteric carbonaceous analog revealed that incorporating the azaborine moiety into the diarylethene scaffold significantly enhances its photochromic performance. This work presents a strategy that employs azaborine chemistry for the development of potential diarylethene-based photoswitchable materials. Full article

Parkinson’s disease (PD) is one of the most prevalent and extensively studied neurodegenerative conditions. One of its most challenging clinical manifestations is the emergence of dyskinesias, characterized by involuntary movements that significantly impair patients’ quality of life. Meanwhile, boron, as a trace element, and boron-containing compounds have emerged as active modulators of neurotransmitter systems. To evaluate the effect of aryl-boroxazolidones on parkinsonism, the in vitro neurotoxicity of three boroxazolidones was assessed, along with the effects of two of them in mice with parkinsonism induced by MPTP administration. Two novel compounds demonstrated a limitation of parkinsonism, whereas risperidone reduced the beneficial effect of the tested boroxazolidones. The three boroxazolidones did not induce toxicity in neurons or glial cells at concentrations up to 100 µM. In silico analyses support the ability of BCC to act as ligands of dopamine and serotonin receptors. Taken together, these results suggest that the tested boroxazolidones are promising candidate agents, warranting further exploration for the treatment of PD. Full article

Elastocaloric cooling, which leverages stress-induced phase transformation in shape memory materials, represents a sustainable and energy-efficient alternative to conventional vapor-compression cooling systems. Central to optimizing these materials is understanding how thermal processing history dictates phase formation, microstructure, and thermal properties. In this study, we investigated the (Ni₅₀Mn_31.5Ti₁₈)_99.8B_0.2 compound synthesized via vacuum induction melting and arc melting, followed by water quenching. Induction melting results in needle-like, boron-rich precipitates within the martensite lattice. In contrast, vacuum arc melting promoted precipitate growth at the grain boundaries. The vacuum arc melting sample exhibits ~82% martensite phase fraction, a near-ambient transformation temperature of ~277 K, a large transition entropy change of ~75 J·kg⁻¹·K⁻¹, and moderate thermal hysteresis of ~24 K. These results underscore the pivotal role of thermal history in tailoring phase stability and transformation thermodynamics, providing essential design guidelines for subsequent mechanical performance optimization in elastocaloric shape memory alloys for energy-efficient and sustainable thermal management applications. Full article

Boron is a chemically distinctive bioelement whose electron-deficient structure enables reversible coordination with oxygen-rich functional groups such as diols and hydroxyls. This property allows boron to modulate molecular stability, conformation, and biological reactivity, giving rise to both beneficial pharmacological effects and toxicological outcomes. This review examines the dual biological role of boron through the framework of bioactive boron-containing natural products and natural compounds capable of forming reversible boron complexes. Particular attention is given to naturally occurring boron-containing antibiotics, including the polyketide macrodiolides boromycin, aplasmomycin, tartrolons, and hyaboron, where boron plays a direct structural and functional role in antimicrobial activity. These compounds demonstrate how boron coordination can influence ion transport, membrane interactions, and molecular assembly, contributing to potent antibacterial properties. Beyond intrinsically boron-containing metabolites, many natural antibiotics and toxins possess oxygen-rich architectures capable of forming transient borate complexes through vicinal 1,2-diol motifs. Examples include polyene macrolide antibiotics such as amphotericin B, fungichromin, and nystatin, as well as tetracyclines, rifamycins, and macrolides such as sorangicin A, where boron coordination may affect solubility, aggregation, ionophoric behavior, and biological selectivity. Similar chemistry is observed in marine neurotoxins and polyether toxins—including tetrodotoxin, saxitoxin derivatives, azaspiracids, pectenotoxins, ciguatoxins, and gambierones—whose hydroxyl-rich frameworks enable reversible interactions with boron species present in seawater. Such complexation may enhance aqueous stability and contribute to trophic transfer and bioaccumulation within marine ecosystems. By framing boron as a molecular “double edge,” this review integrates chemical, biological, and environmental perspectives to highlight how boron coordination can simultaneously enhance antimicrobial activity while influencing toxicity and ecological persistence. Recognizing the role of boron in shaping the activity of natural products provides new insight into antibiotic function, toxin behavior, and the broader impact of boron chemistry in biological systems. Full article

Poly(amidoamine) (PAMAM) and poly-L-lysine (PLL) dendrimers have emerged as highly versatile macromolecular platforms with significant potential in biomedical applications, owing to their well-defined architecture, tunable surface chemistry, and capacity for multivalent functionalization. Their ability to carry substantial molecular payloads and to be engineered for selective interactions with biological systems has positioned them as attractive candidates for targeted drug delivery, including the transport of boron-rich compounds. Recent advances in dendrimer chemistry have enabled the incorporation of boron clusters into PAMAM and PLL structures, creating hybrid systems designed to enhance cellular uptake, improve tumor selectivity, and increase boron accumulation within malignant tissues. Given the growing interest in boron neutron capture therapy (BNCT), the integration of boron clusters into dendrimer structures represents a particularly promising direction for enhancing boron delivery to tumors. This manuscript reviews current knowledge on PAMAM and PLL dendrimers and their boron-functionalized derivatives, summarizing findings from cell culture studies, in vivo models, and clinical or preclinical investigations. Particular attention is given to both the advantageous properties of these dendrimers—such as improved delivery efficiency and biocompatibility—and their potential undesirable biological effects. As such, PAMAM and PLL dendrimers represent an important and evolving class of carriers that may significantly advance the effectiveness of boron neutron capture therapy (BNCT) in cancer treatment. Full article

Boron compounds, classified as prohibited food additives due to their high toxicity, persist in pesticides and fertilisers, industrial processes, food supply chains, and consumer goods, perpetuating multisource exposure risks. Chronic ingestion may induce fatal hepatorenal injury; however, mechanistic insights and epidemiological surveillance remain critically lacking amidst sector-wide regulatory gaps. This study employed integrated cellular and organismal models to elucidate the relationship between boron-induced hepatotoxicity and ferroptosis. We demonstrate that dietary boron accumulation in chicken livers is associated with histopathological damage, mitochondrial cristae dissolution and atrophy (a hallmark of ferroptosis), and elevated serum biomarkers AST and ALT. Boron exacerbates oxidative damage in hepatocytes by elevating malondialdehyde (MDA) production while modulating the Nrf2/ARE antioxidant signaling pathway—specifically downregulating key genes (Nrf2, HO-1, GCLM, CAT). Concurrently, it inhibits critical antioxidant enzymes (SOD, T-AOC), thereby depleting cellular antioxidant defenses. Crucially, boron disrupts iron homeostasis and induces ferroptosis by dysregulating the SLC7A11-GPX4 pathway: upregulating pro-ferroptotic genes (ACSL4, TF, TFR) and downregulating cytoprotective genes (SLC7A11, GPX4, FTH1). Co-treatment with the ferroptosis inhibitor ferrostatin-1 (Fer-1) attenuated boron-induced oxidative damage, whereas the ferroptosis inducer Erastin potentiated toxicity. Collectively, we pioneer the dual-pathogenic mechanism of boron hepatotoxicity—oxidative stress and ferroptotic cell death—establishing the SLC7A11/GPX4 axis as a novel therapeutic target against boron toxicity. Full article

Ciprofloxacin (CIP) is an antibiotic that is widely used in humans and animals. However, the compound has been detected in animal-derived products and the environment due to its extensive use, causing serious concern for public health and environmental safety. The issue raises the urgent need to develop innovative techniques to monitor CIP. Therefore, this study aims to develop a simple and sensitive CIP sensor called the boron-doped diamond nanoparticle-modified screen-printed electrode (BDD NPs/SPE) and the nickel oxide nanoparticle-modified BDD NPs/SPE (NiO NPs/BDD NPs/SPE). NiO NPs were synthesized via green synthesis using Spatholobus littoralis Hassk. root extract as the reducing agent. The formation and characteristics of NiO NPs were then confirmed through a UV-Vis spectrophotometer, XRD, PSA, FT-IR, and XPS. The successful modification of SPE was confirmed through SEM-EDX, followed by measurements using square-wave voltammetry. The results showed that the modified SPE could detect CIP over a concentration range of 0.1–100 µM and produced a low detection limit of 0.109 µM for BDD NPs/SPE and 0.054 µM for NiO NPs/BDD NPs/SPE. The proposed method was successfully applied to the determination of CIP in commercial tablets, milk, and human urine, with a satisfactory % recovery from 95 to 100%. The current study successfully developed a simple yet highly sensitive sensor that enabled robust, reliable, and efficient detection of CIP, showing its strong potential for practical applications. Full article

Garlic (Allium sativum L.) is a significant crop cultivated worldwide for its culinary, nutritional, and medicinal value. This study aimed to evaluate the effects of different fertilization regimes on the bioactive compounds, antioxidant activity, nutritional value, and mineral composition of garlic. The field experiment was conducted at the Institute of Field and Vegetable Crops, in three replications. Fertilization significantly influenced the bioactive compounds, antioxidant activity, nutritional quality, and mineral composition of garlic. Cattle manure proved to be the most effective treatment, increasing protein (by approx. 5.1%), total sugars (17.9%), sucrose (24.9%), sulfur content (7.2%), total phenolics (3.1%), flavonoids (30.7%), and antioxidant activity (by 5.2–23.1% depending on the assay) compared to the control, indicating superior nutritional and functional quality. Multivariate analyses highlighted the significant impact of fertilization regimes on garlic quality, with mineral fertilizer, control (treatment without fertilizer application), and cattle manure enhancing bioactive compounds, antioxidant activity, and nutritional composition. Fertilization had limited effects on macroelements, although cattle and sheep manure increased nitrogen and sulphur contents, while molasses reduced phosphorus and potassium levels. Organic fertilization significantly modified microelement composition, with sheep manure notably increasing zinc and copper, while most fertilizers reduced boron, iron, and sodium contents compared with the control. Animal-based fertilizers, particularly cattle manure, provide a sustainable alternative to mineral fertilization, enhancing garlic’s dry matter, nutritional and bioactive compounds, and antioxidant activity. Full article

BNCT (Boron Neutron Capture Therapy) is a binary radiotherapeutic modality in which high LET (Linear Energy Transfer) particles are generated from ¹⁰B(n,α)⁷Li reaction, ideally within boron-loaded tumour cells, so the therapeutic outcome depends critically on the pharmacokinetics and biodistribution of boron carriers. In this review, boron-containing agents for BNCT, with a focus on ADMET (absorption, distribution, metabolism, excretion and toxicity) and model-informed design, were examined. Low-MW (low-molecular-weight) compounds, peptide conjugates, polymeric and nanostructured platforms and cell-based vectors were surveyed and how physicochemical properties, transporter engagement and nano–bio interactions govern tumour uptake, subcellular localisation and normal tissue exposure were discussed. A shift from maximising boron content towards optimising exposure profiles using PET (Positron Emission Tomography), PBK (physiologically based pharmacokinetic) modelling and in silico ADMET tools to define irradiation windows was also discussed. Classical agents such as BPA (Boronophenylalanine) and BSH (Sodium Borocaptate) are contrasted with newer polymeric and metallacarborane-based carriers, with attention to brain penetration, endosomal escape, linker stability, biodegradation and elimination routes, as well as platform-specific toxicities. Incontestably, further progress in BNCT will highly depend on integrating imaging-derived kinetics with PBPK-informed dose planning and engineering subcellularly precise yet degradable carriers, and that ADMET-guided design and spatiotemporal coordination are central to achieving reproducible clinical benefit from BNCT’s spatial selectivity. Full article

Boron neutron capture therapy (BNCT) is experiencing a global resurgence driven by advances in boron pharmacology, accelerator-based neutron sources, and molecular imaging-guided theranostics. BNCT produces high linear energy transfer particles with micrometer-range energy deposition, enabling cell-selective irradiation confined to boron-enriched tumor cells in a geometrically targeted region by the neutron beam. This mechanism offers the potential for exceptionally high therapeutic ratios, provided two core requirements are met: sufficient differential tumor uptake of ¹⁰B and a neutron beam with appropriate energy and penetration. After early clinical attempts in the mid-20th century were hindered by inadequate boron agents and reactor-based neutron beams, recent technological breakthroughs have made BNCT clinically viable. The development of hospital-compatible accelerator neutron sources, next-generation boron delivery systems (such as receptor-targeted compounds and nanoparticles), advanced theranostic approaches (such as ¹⁸F-BPA positron emission tomography and boron-sensitive magnetic resonance imaging), and AI-driven biodistribution modeling now support personalized treatment planning and patient selection. These innovations have catalyzed modern clinical implementation, exemplified by Japan’s regulatory approval of BNCT for recurrent head and neck cancer and the rapid expansion of clinical programs across Asia, Europe, and South America. Building on these foundations, BNCT has transitioned from a predominantly academic experimental modality into an increasingly commercialized and industrially supported therapeutic platform. The emergence of dedicated BNCT companies, international collaborations between accelerator manufacturers and hospitals, and pharmaceutical development pipelines for next-generation boron carriers has accelerated clinical translation. Moreover, BNCT now occupies a unique position among radiation modalities due to its hybrid nature, namely combining the biological targeting of radiopharmaceutical therapy with the external-beam controllability of radiotherapy, thereby offering new therapeutic opportunities where competitive approaches fall short. Emerging evidence suggests therapeutic promise in glioblastoma, recurrent head and neck cancers, melanoma, meningioma, lung cancer, sarcomas, and other difficult-to-treat malignancies. Looking ahead, continued innovation in compact neutron source engineering, boron nanocarriers, multimodal theranostics, microdosimetry-guided treatment planning, and combination strategies with systemic therapies such as immunotherapy will be essential for optimizing outcomes. Together, these converging developments position BNCT as a biologically targeted and potentially transformative modality in the era of precision oncology. Full article

The photophysical properties of a BODIPY derivative with the highly twisted molecular structure of anthracene-fused boron–dipyrromethene (AN-BDP) were studied with steady-state and time-resolved spectroscopic methods. The fused anthryl and the BDP units in AN-BDP units both adopt distorted geometry (with ca. 10° of torsion), and there is large dihedral angle between the two units (ca. 49.7°). Interestingly, the fluorescence quantum yields are highly dependent on the solvent polarity (59~3%, from toluene to acetonitrile), yet the fluorescence emission wavelength does not change in different solvents. Nanosecond transient absorption spectra indicate that the triplet state is long-lived, with an intrinsic triplet state lifetime of 551 μs. Interestingly the severely twisted structure only shows a moderate intersystem crossing (ISC) yield (10%). Femtosecond transient absorption spectra indicate slow ISC (>1.5 ns), which is in agreement with the fluorescence lifetime (2.3 ns). Time-resolved electron paramagnetic resonance (TREPR) spectra show smaller zero-field-splitting D and E tensors as (−71.4 mT, 16.7 mT, respectively) compared to the triplet state of the iodinated native BDP (D = −104.6 mT, E = 22.8 mT), inferring that the triplet-state wave function of the new compound is delocalized over the twisted molecular framework. The theoretical computation indicated a solvent-polarity-dependent energy barrier for the relaxed S₁ state to a conical interaction (CI) of the S₁ and the S₀ state potential curves, which agrees with the weaker fluorescence in polar solvents. Full article

Hypoeutectic aluminum–silicon casting alloys in their unmodified state have a coarse-grained eutectic (α + β), which results in poor mechanical properties and brittleness. Microstructure refinement and improved mechanical properties are possible, among other things, by introducing various elements and chemical compounds. The literature presents numerous studies on the modification of hypoeutectic silumins, but there are no results confirming the effectiveness of the interaction of a master alloy containing titanium and boron with its main component, which may be aluminum, aluminum with silicon, or aluminum with silicon and magnesium. This paper presents the results of microstructure refinement using titanium or boron introduced into the Al, AlSi7, and AlSi7Mg master alloys. The introduction of titanium and boron into the aluminum-based master alloy resulted in microstructure refinement and improved mechanical properties. The results indicate that the most favorable results were obtained when titanium and boron were introduced into the AlSi7 master alloy. The addition of magnesium to the master alloy AlSi7 resulted in less effective microstructure refinement of the AlSi9 silumin, which resulted in lower mechanical properties than those obtained for the master alloy without Mg. Full article

Boron-dipyrromethene (BODIPY) dyes belong to a class of organoboron compounds that have become ubiquitous for researchers in areas of fluorescence imaging, photodynamic therapy, and optoelectronics. The intrinsic qualities of BODIPY dyes and their meso-modified structural analogs, Aza-BODIPY dyes, have propelled their recent increase in use in biomedical applications. The two scaffolds have high quantum yields, narrow absorption, and emission bandwidths with large Stokes’ shifts, and high photostability and thermal stability. Because their properties are independent of solvent polarity and dye functionality, they can be tuned to promote novel analytical methods, resulting in the adaptation of the physicochemical and spectral properties of the dyes. In this review of BODIPY and Aza-BODIPY scaffolds, we will summarize their spectral properties, synthetic methods of preparation, and applications reported between 2014 and 2025. This review aims to summarize the advances in chemosensing, especially pH sensor development, and the advances in NIR-II window bioimaging probes. We hope that this succinct overview of Aza-BODIPY scaffolds will highlight their untapped potential, elucidating insights that may catalyze novel ideas in the physical organic realm of BODIPY. Full article

This work explores a novel and efficient synthetic approach to a new class of boron cluster derivatives via the nucleophilic addition of stabilized phosphorus ylides, Ph₃P=CHR² (R² = COOEt, CN), to a series of nitrilium salts of the closo-decaborate anion, [2-B₁₀H₉NCR¹]⁻ (R¹ = Me, Et, ⁿPr, ⁱPr, Ph). The reaction proceeds regio- and stereospecifically, affording a diverse range of iminoacyl phosphorane derivatives, [2-B₁₀H₉NH=C(R¹)C(PPh₃)R²]⁻, in high isolated yields (up to 95%). The obtained compounds (10 examples) were isolated as tetrabutylammonium or tetraphenylphosphonium salts and thoroughly characterized by multinuclear NMR (¹¹B, ¹H, ¹³C, ³¹P), high-resolution mass spectrometry, and single-crystal X-ray diffraction. The reaction feasibility was found to be strongly influenced by the steric hindrance of the R¹ group. Furthermore, the practical utility of these novel hybrids was demonstrated by employing the [2-B₁₀H₉NH=C(CH₃)C(COOC₂H₅)=PPh₃]⁻ anion as a highly effective membrane-active component in ion-selective electrodes. The developed tetraphenylphosphonium (TPP⁺) sensor exhibited a near-Nernstian response, a low detection limit of 3 × 10⁻⁸ M, and excellent selectivity over a range of common inorganic and organic cations, showcasing the potential of closo-borate-based ionophores in analytical chemistry. Full article